Amnion

Key Patents: US-9662257 | US-11679050 | EP-3370676 | JP-6755949

Amniobed™
TECHNOLOGY

Our Overview

Introducing the Amniobed™: A Womb-Like Environment for Preterm Infants

The Amniobed™ provides preterm infants with a synthetic, womb-like environment, supporting development through controlled temperature, humidity, and gentle fluid movement. This breakthrough technology reduces stress and promotes healthier growth during critical early stages.

Technology Breakdown

The Amniobed™ features a unique synthetic amniotic fluid that mimics the protective environment of the womb. This fluid gently cushions preterm infants, reducing external stress and providing the ideal conditions for growth and development. By closely replicating the natural environment, the synthetic fluid helps to support organ development and overall well-being.
Maintaining a stable body temperature is a critical challenge for preterm infants. The Amniobed™ incorporates precise thermal control systems that ensure the optimal temperature is maintained throughout care. This helps prevent temperature fluctuations that can stress a newborn’s developing body, allowing for better stability and improved outcomes.
The Amniobed™ is equipped with advanced monitoring systems that carefully manage the balance of fluids, helping to prevent both dehydration and fluid overload. By continuously adjusting the fluid levels and flow, the system ensures a stable environment, supporting the infant’s delicate fluid needs while promoting safe, healthy growth.

intellectual property

Key Claims of Patented Technology

Synthetic Amniotic Fluid Partial Infant Submersion Safety Mechanisms
Fluid Management System

Number of Patents Issued Globally

4 United States
2 China
1 Japan
1 France
1 Germany
1 Great Britain

Scientific Validation:

Backed by Science

The Amniobed™ is grounded in rigorous scientific research and development, designed in collaboration with leading experts in neonatology and medical technology. Our approach is built on evidence-based practices, ensuring that every aspect of the device is thoroughly tested for safety and effectiveness. From concept to clinical implementation, Amnion Life is committed to advancing neonatal care through innovation supported by scientific validation.

Prototype to Clinical Trials:

From Concept to Care

Amnion Life has progressed from a visionary concept to the development of a functional prototype, aimed at transforming neonatal care. The Amniobed™ is currently undergoing rigorous testing to ensure it meets the highest standards of safety and effectiveness. As we move forward, our focus is on preparing for clinical trials within the next year, working closely with medical experts and research institutions to validate the device’s potential impact. With a commitment to regulatory compliance, we are actively pursuing the necessary pathways to bring this innovative solution to NICUs, making a meaningful difference in the care of preterm infants.”

Global Reach and Collaborations

At Amnion Life, we continuously explore new frontiers in neonatal and intensive care. Concepts like artificial placenta technology and targeted medication delivery inspire our vision for advancing fetal development.

Beyond neonatal care, we see potential for our technology in specialized treatment for burn patients and the elderly, providing controlled, therapeutic environments to enhance recovery. Though still in the conceptual stage, these ideas reflect our commitment to redefining possibilities in life-saving care